How Has the Cannabis Use Disorder Market Size Evolved in Recent Years?
The cannabis use disorder market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for cannabis use disorder has seen significant growth. The estimated market growth will escalate from $1.53 billion in 2024 to $1.66 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.9%.
The driving factors for this continued growth in the past can be attributed to the decriminalization and legalization of cannabis, heightened societal understanding of mental health and addiction, expansion of research and medical studies on cannabis, advancements in addiction therapy and behavioral treatment, and the augmented access to treatments via digital health channels.
What are the Market Size and Expected Growth Rates for the Cannabis Use Disorder Market?
The cannabis use disorder market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for significant expansion in the cannabis use disorder market in the coming years. By 2029, the market is predicted to reach a total value of $2.22 billion, growing at a compound annual rate (CAGR) of 7.5%.
This projected growth can be linked to several factors including the ongoing legalization and regulation of cannabis, increased recognition and focus on mental health and integrated care models, advancements in related pharmacological treatments and FDA approvals alongside the emergence of digital therapeutics and telehealth services, and heightened investment in research and evidenced-based treatments. The forecast period is set to see trends such as the rise of digital and mobile health solutions, emerging research into psilocybin-assisted therapy, improved treatment options, embracing personalized medicine, and breakthroughs in biotechnology.
What Are The Key Drivers Fueling Growth In The Cannabis Use Disorder Market?
The ascension in recognition and detection of cannabis addiction is projected to accelerate the expansion of the cannabis use disorder market. The procedures include educating the general public, medical professionals, and individuals about the indications, signs, and dangers of cannabis use disorder (CUD). The surge in recognition and detection of cannabis addiction is attributed to various elements like heightened cannabis legalization & accessibility and escalating scientific & medical cognizance. The treatment of cannabis use disorder provides a systematic plan to cope with withdrawal indicators, curtail cravings, and tackle the foundational psychological elements. This supports the detection of cannabis addiction by offering clinical proof of dependency routines, emphasizing the seriousness of the illness, and steering the suitable level of intervention depending on the specific needs of the individual. For example, in December 2023, as per the data of the Office for Health Improvement and Disparities, a governmental department based in the UK, there has been a 2% increase in the count of people seeking assistance for cannabis-related problems this year, going up from 28,263 in 2021 to 28,845 in 2022. As a result, the rise in recognition and detection of cannabis addiction fuels the expansion of the cannabis use disorder market.
What Are The Key Segments Within The Global Cannabis Use Disorder Market?
The cannabis use disorder market covered in this report is segmented –
1) By Treatment: Pharmacotherapy, Behavioral Therapies
2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual
3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
Subsegments:
1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Antipsychotics, Benzodiazepines
2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy
Pre-Book The Cannabis Use Disorder Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Cannabis Use Disorder Market?
Principal players in the market for cannabis use disorder are channeling their efforts into creating innovative solutions for substance use management. This is to offer individualized care to those battling cannabis addiction. Substance use management solutions serve as comprehensive systems designed to prevent, treat, and control substance use disorders, thereby enabling individuals to overcome cannabis dependency. Their focus extends to long-term recovery, averting potential relapses, and promoting an overall sense of well-being. For example, in April 2024, a U.S.-based virtual clinic called Pelago, which specializes in substance use management, rolled out a treatment program for cannabis use disorder (CUD). This program is crafted to tackle the escalating incidence of CUD in the U.S, where it affects nearly 18 million adults. Pelago's strategy encompasses enlightening individuals about the implications of cannabis use and facilitating access to proven care measures including cognitive-behavioral therapy and motivational enhancement therapy. The program is also tailored to cater to adolescents from 15-17 years, with a central focus on promoting abstention.
Who Are the Key Players In The Cannabis Use Disorder Market?
Major companies operating in the cannabis use disorder market are:
• Lyra Health Inc.
• Pyramid Healthcare Inc.
• Hazelden Betty Ford Foundation
• Charlie Health
• Caron Treatment Center
• Promises Behavioral Health
• Sierra Tucson
• Samarpan
• Affect Therapeutics Inc.
• Cadabam's Rehabilitation Center
• Aelis Farma
• Skywood Recovery
• Pelago
• PleoPharma Inc.
• Abhasa
• Marijuana Anonymous
• Northpoint Colorado
• Sukoon Health
• Granite Mountain Behavioral Healthcare
• GreeneStone
What Are The Regional Insights Into The Cannabis Use Disorder Market?
North America was the largest region in the cannabis use disorder market in 2024. The regions covered in the cannabis use disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
